Jiangsu Aidea Pharmaceutical Co Ltd
医疗健康 · 生物科技
Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. It offers anti-HIV drugs and human-derived proteins. The company also provides anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July 2025. Jiangsu Aidea Pharmaceutical Group Co., Ltd. was founded in 2009 and is headquartered in Yangzhou, China.
MARKET 市值 6.03B CNY 52W ¥11.4 – ¥22.55
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG — 营收 YoY -10.0%
▼ ROE -0.3% 营业利润率 11.8% 净利润率 -3.9%